| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/15/2004 | US20040009907 Nucleic acids encoding cytoplasmic, nuclear, membrane bound, and secreted polypeptides, as well as vectors, host cells, antibodies, and recombinant methods for production |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009900 Soluble molecular complex comprising an expressible gene encoding the secretory protein complexed with a carrier of a cell-specific binding agent and a gene-binding agent which releases the gene under intracellular conditions |
| 01/15/2004 | US20040009899 Treating dominant disorders |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009892 Method for the identification and use of substances that modulate POD function and/or structure |
| 01/15/2004 | US20040009612 Analyzing nucleotide sequences and detecting restriction fragment length polymorphisms; forensics; heredity testing |
| 01/15/2004 | US20040009604 Plasmid which codes envelop fusogenic membrane protein for treating cell proliferative disorders; antitumor agents; immunotherapy; gene therapy |
| 01/15/2004 | US20040009603 Antiviral vectors |
| 01/15/2004 | US20040009602 DNA modifying molecules and methods of use thereof |
| 01/15/2004 | US20040009601 Methods for the regeneration and transformation of cotton |
| 01/15/2004 | US20040009599 Antisense modulation of cellular inhibitor of apoptosis-1 expression |
| 01/15/2004 | US20040009597 Oligonucleotides for controlling protein tyrosine phosphatase receptor type K gene expression activity and treating diabetes, inflammation and cancer; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009579 Using microorganisms with restricted colonial and/or extensive hyphal branching phenotypes as bioreactors for expression of heterologous polypeptides |
| 01/15/2004 | US20040009575 Vibro expression vector for transferring heterologous nucleotide sequences into cells |
| 01/15/2004 | US20040009569 Kinase crystal structures and materials and methods for kinase activation |
| 01/15/2004 | US20040009568 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 01/15/2004 | US20040009561 Comprises enzymatic polypeptide with amino acid oxidase activity for preparation of chemical intermediates for antibiotics and hypotensive agents |
| 01/15/2004 | US20040009560 Directing the ration of B2:B1 avermectins in Streptomyces avermitilis host cells |
| 01/15/2004 | US20040009558 Ligand binding pocket peptide fragment of the estrogen-related receptor 3 (ERR3) and uses thereof |
| 01/15/2004 | US20040009557 Comprises nucleotide sequences coding non-gum arabic fusion protein for use in food processing and cosmetics |
| 01/15/2004 | US20040009556 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/15/2004 | US20040009555 Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009549 Method for detecting remote homologues and novel kinases identified with the method |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009544 Thermolabile caffeine fraction of tea leaves and an efficient method of introducing Agrobacterium-mediated genetic transformation in plants |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009530 Engineered binding proteins |
| 01/15/2004 | US20040009525 Nucleic-acid probe substrate, system for temperature control of the substrate, and gene detection method making use of the same |
| 01/15/2004 | US20040009524 Transfecting cells with two vectors, measuring transcription activity of androgen receptor protein, a transcription factors, interaction between receptor protein and co-modulator; medical diagnosis |
| 01/15/2004 | US20040009522 Methods of selecting 5'-capped nucleic acid molecules |
| 01/15/2004 | US20040009520 Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| 01/15/2004 | US20040009519 Method for detecting protozoa of the genus Naegleria |
| 01/15/2004 | US20040009518 Methods for evaluating a disease condition by nucleic acid detection and fractionation |
| 01/15/2004 | US20040009510 Single stranded DNA or RNA is enzymatically catalyzing a chemical reaction, cleavaging a predetermined diseased nucleic acid molecule; polymerases |
| 01/15/2004 | US20040009507 Concatenated nucleic acid sequence |
| 01/15/2004 | US20040009506 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 01/15/2004 | US20040009505 A pair of genetic engineered primers for the mutagenic amplification, therapeutic treatment |
| 01/15/2004 | US20040009499 Method and system for allergy analysis |
| 01/15/2004 | US20040009497 Methods and reagents for dendritic localization of polynucleotides |
| 01/15/2004 | US20040009493 Detection of chromosomal abnormalities, such as a chromosomal aneuploidies, deletions, amplifications, and the diagnosis or prognosis of syndromes associated with a contiguous gene abnormality; Kits |
| 01/15/2004 | US20040009492 Amplification with a high specificity, a high speed, a high sensitivity and a low cost through a multiplex PCR to detect a maturity-onset of diabetes of the young (MODY) 2 associated gene |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009490 Polynucleotides isolated from Lactobacillus rhamnosus, oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, organisms incorporating them |
| 01/15/2004 | US20040009487 Comprises applying a blocking reagent to the microarray, the blocking reagent comprises modified nucleotide bases, preferably LNA (Locked Nucleic Acid-modified bicyclic monomeric units with a 2'-O-4'-C methylene bridge) |
| 01/15/2004 | US20040009485 Cellular arrays for the identification of altered gene expression |
| 01/15/2004 | US20040009483 Method of linear mRNA amplification using total RNA |
| 01/15/2004 | US20040009479 Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| 01/15/2004 | US20040009477 Methods for producing libraries of expressible gene sequences |
| 01/15/2004 | US20040009476 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/15/2004 | US20040009475 Tumor cells to cytotoxic chemotherapeutic agents, especially antimetabolites and agents that damage DNA; excision repair cross-complementing (ERCC1) gene; thymidylate synthase (TS) |
| 01/15/2004 | US20040009470 Methods to define and validate the interaction of phage-displayed proteins with their targets in terms of the strength of this interaction |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009468 Allelic variants of HERV-K18, method for analysis thereof and use in the determination of genetic predisposition for disorders involving the HERV-K18 provirus |
| 01/15/2004 | US20040009466 Determining candidates for gene deletions and additions using a model of a metabolic network associated with an organism, the model includes a plurality of metabolic reactions defining metabolite relationships |
| 01/15/2004 | US20040009193 Lipid bilayer membrane derived from a eukaryotic microorganism as an outer membrane |
| 01/15/2004 | US20040009192 Diagnosis of and vaccination against |
| 01/15/2004 | US20040009191 Inactivated virulence genes |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009178 Human neutralizing antibodies (full-length or functional fragments) are useful as antitoxins or antiinfectives with respect to infective agents such as anthrax, botulinum, smallpox, Venezuelan equine encephalomyelitis, West Nile virus |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009164 PSP94 diagnostic reagents and assays |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009156 Synergistic mixtures comprising drugs such as cisplatin and cytoplasmic motor proteins, used as anticarcinogenic agents |
| 01/15/2004 | US20040009153 GP64-null baculoviruses pseudotyped with heterologous envelope proteins for gene therapy |
| 01/15/2004 | US20040009151 Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal |
| 01/15/2004 | US20040009122 A formulation V-L-R where v is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker or a bond and R is a detectable moiety (v is nonpeptidic or peptide and R is a macromolecule) |
| 01/15/2004 | DE10230147A1 Verfahren zur unspezifischen Anreicherung von Bakterienzellen Method for non-specific enrichment of bacterial cells |
| 01/15/2004 | DE10229978A1 Verfahren zur Herstellung von konjugierter Linolsäure in Pflanzen Process for the preparation of conjugated linoleic acid in plant |
| 01/15/2004 | DE10229729A1 Neue Nukleinsäuresequenzen und deren Verwendung in Verfahren zum Erreichen einer Pathogenresistenz in Pflanzen New nucleic acid sequences and to their use in methods for obtaining a pathogen resistance in plants |
| 01/15/2004 | DE10227001A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen A method for identifying fungicidally active compounds |
| 01/15/2004 | DE10111520B4 Verfahren zur Aufreinigung von Biomolekülen mit Hilfe magnetischer Partikel A process for purifying biomolecules with the aid of magnetic particles |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2493860A1 Marker genes for determining renal toxicity |
| 01/15/2004 | CA2492124A1 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491907A1 Oncolytic virus replicating selectively in tumor cells |
| 01/15/2004 | CA2491847A1 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 01/15/2004 | CA2491690A1 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | CA2491687A1 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | CA2491669A1 Neoplasm specific antibodies and uses thereof |
| 01/15/2004 | CA2491639A1 Expression of the human igf-1 in transgenic plastids |
| 01/15/2004 | CA2491637A1 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | CA2491627A1 Glucose dehydrogenase |
| 01/15/2004 | CA2491607A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | CA2491591A1 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | CA2491497A1 Antisense modulation of insulin-like growth factor 2 expression |
| 01/15/2004 | CA2491471A1 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | CA2491411A1 The rice restorer gene to the rice bt type cytoplasmic male sterility |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491143A1 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 01/15/2004 | CA2491137A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/15/2004 | CA2491064A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | CA2491056A1 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | CA2491026A1 Diagnosis of sepsis using mitochondrial nucleic acid assays |